TY  - GEN
AU  - Berenson,James R
AU  - Yellin,Ori
AU  - Patel,Ravi
AU  - Duvivier,Herb
AU  - Nassir,Youram
AU  - Mapes,Russell
AU  - Abaya,Christina DiLauro
AU  - Swift,Regina A
TI  - A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma
SN  - 1078-0432
PY  - 2009///0716
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Boronic Acids
KW  - administration & dosage
KW  - Bortezomib
KW  - Combined Modality Therapy
KW  - Drug Administration Schedule
KW  - Ethylenediamines
KW  - Humans
KW  - Maximum Tolerated Dose
KW  - Multiple Myeloma
KW  - therapy
KW  - Organophosphonates
KW  - Platelet Count
KW  - Pyrazines
KW  - Radioisotopes
KW  - Recurrence
KW  - Samarium
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-1261
ER  -